FENOFIBRATE IMPROVES LIVER TESTS IN PRIMARY SCLEROSING CHOLANGITIS WITH INCOMPLETE BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID

被引：0
|
作者：
Chazouilleres, Olivier [1 ,2 ]
Corpechot, Christophe [1 ,2 ]
Gaouar, Farid [1 ]
Poupon, Raoul [1 ,2 ]
机构：
[1] Hop St Antoine, APHP, Serv Hepatol, Ctr Reference Malad Inflammatoires Voies Biliaire, F-75571 Paris, France
[2] Univ Paris 06, Fac Med St Antoine, UMR S938, Paris, France
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
336
引用
收藏
页码：488A / 488A
页数：1
相关论文
共 50 条
  • [41] Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease
    Cortez-Pinto, Helena
    Liberal, Rodrigo
    Lopes, Susana
    Machado, Mariana, V
    Carvalho, Joana
    Dias, Teresa
    Santos, Arsenio
    Agostinho, Claudia
    Figueiredo, Pedro
    Loureiro, Rafaela
    Martins, Alexandra
    Alexandrino, Goncalo
    Cotrim, Isabel
    Leal, Carina
    Presa, Jose
    Mesquita, Monica
    Nunes, Joana
    Gouveia, Catarina
    Vale, Ana Horta E.
    Alves, Ana Luisa
    Coelho, Mariana
    Maia, Luis
    Pedroto, Isabel
    Banhudo, Antonio
    Pinto, Joao Sebastiao
    Gomes, Marta Vargas
    Oliveira, Joana
    Andreozzi, Valeska
    Calinas, Filipe
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2021, 9 (06) : 699 - 706
  • [42] Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience
    Lemoinne, Sara
    Pares, Albert
    Reig, Anna
    Ben Belkacem, Karima
    Fankem, Astrid Donald Kemgang
    Gaouar, Farid
    Poupon, Raoul
    Housset, Chantal
    Corpechot, Christophe
    Chazouilleres, Olivier
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (06) : 521 - 528
  • [43] Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis. the More the Better?
    Muller, T.
    Baumgart, D. C.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2010, 48 (05): : 569 - 570
  • [44] High-Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis
    Lindor, Keith D.
    Kowdley, Kris V.
    Luketic, Velimir A. C.
    Harrison, M. Edwyn
    McCashland, Timothy
    Befeler, Alex S.
    Harnois, Denise
    Jorgensen, Roberta
    Petz, Jan
    Keach, Jill
    Mooney, Jody
    Sargeant, Carol
    Bernard, Tamara
    King, Debra
    Miceli, Ellen
    Schmoll, Jeff
    Hoskin, Tanya
    Thapa, Prabin
    Enders, Felicity
    HEPATOLOGY, 2009, 50 (03) : 808 - 814
  • [45] High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
    Smith T.
    Befeler A.S.
    Current Gastroenterology Reports, 2007, 9 (1) : 54 - 59
  • [46] RESOLUTION OF RADIOGRAPHIC ABNORMALITIES WITH URSODEOXYCHOLIC ACID THERAPY OF PRIMARY SCLEROSING CHOLANGITIS
    LEBOVICS, E
    SALAMA, M
    ELHOSSEINY, A
    ROSENTHAL, WS
    GASTROENTEROLOGY, 1992, 102 (06) : 2143 - 2147
  • [47] The efficacy of ursodeoxycholic acid (UDCA) in the treatment of primary sclerosing cholangitis in children
    Gilger, MA
    Gann, ME
    Opekun, AR
    Gleason, WA
    GASTROENTEROLOGY, 1999, 116 (04) : A10 - A10
  • [48] Primary sclerosing cholangitis: neoplastic potential and chemopreventive effect of ursodeoxycholic acid
    Stiehl, A
    Rost, D
    Gastroenterology Yesterday - Today - Tomorrow: A Review and Preview, 2005, 144 : 196 - 202
  • [49] PRIMARY SCLEROSING CHOLANGITIS What is the role of ursodeoxycholic acid in therapy for PSC?
    Chapman, Roger W.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (02) : 74 - 75
  • [50] Use of Fenofibrate for patients with primary Sclerosing Cholangitis
    Abdalla, Sherine M.
    Dejman, Adriana
    Clark, Virginia
    Levy, Cynthia
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (03) : E33 - E36
12345